L. plantarum P17630 (Proge P17630), Rosell A, is a unique strain isolated from a healthy vaginal flora with full mechanistic and clinical evidence of efficacy to support and maintain an equilibrium of a normal vaginal microflora, even when taken orally (5B CFU / day), in women prone to experience temporary imbalances in their vaginal microflora. This probiotic strain is one of the most documented in the world in the women’s health area, as it has been studied in over 800 women, in six clinical studies, including two by oral intake. In combination or not with conventional treatments for candidiasis (anti-fungal) women will see an improvement in candidiasis with a decrease in symptoms including less swelling, redness, burning or itching. This probiotic strain will also help reduce the risk of recurrence of this candidiasis.
10 truths about Rosell A from Lallemand Health Solutions
- Is scientifically backed by mechanistic data and six clinical studies (including two with oral treatment), involving over 800 women
- Adheres and interferes with C. albicans (in vitro studies).
- Demonstrates vaginal colonization and persistence following oral intake (validated efficacy dose: 5B/day).
- Normalizes power of hydrogen (pH).
- Restores flora diversity associated with a healthy vaginal flora.
- Promotes vaginal diversity associated with a healthy vaginal microbiota.
- Helps promote vaginal health in recurrent Vulvovaginal Candidiasis as adjunctive treatment with triazole or alone.
- Helps promote continued vaginal health in Vulvovaginal Candidiasis.
- Helps promote vaginal health in recurrent Vulvovaginal Candidiasis.
- Unique strain with full story and clinical studies on recurrent Vulvovaginal Candidiasis.
Visit www.lallemand-health-solutions.com/rosella
